US20080114277A1 - Porous bioresorbable dressing conformable to a wound and methods of making same - Google Patents
Porous bioresorbable dressing conformable to a wound and methods of making same Download PDFInfo
- Publication number
- US20080114277A1 US20080114277A1 US11/983,548 US98354807A US2008114277A1 US 20080114277 A1 US20080114277 A1 US 20080114277A1 US 98354807 A US98354807 A US 98354807A US 2008114277 A1 US2008114277 A1 US 2008114277A1
- Authority
- US
- United States
- Prior art keywords
- dressing
- wound site
- wound
- solvent
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00536—Plasters use for draining or irrigating wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1002—Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
- Y10T156/1005—Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina by inward collapsing of portion of hollow body
Definitions
- the present invention relates generally to methods, systems and compositions for making and using porous bioresorbable dressing in various configurations.
- Wound healing may be broadly split into three overlapping basic phases: inflammation, proliferation, and maturation.
- the inflammatory phase is characterized by hemostasis and inflammation.
- the next phase consists mainly of epithelialization, angiogenesis, granulation tissue formation, and collagen deposition.
- the final phase includes maturation and remodeling.
- the complexity of the three step wound healing process is augmented by the influence of local factors such as ischemia, edema, and infection, and systemic factors such as diabetes, age, hypothyroidism, malnutrition, and obesity.
- the rate limiting step of wound healing is often angiogenesis.
- Wound angiogenesis is marked by endothelial cell migration and capillary formation where the sprouting of capillaries into the wound bed is critical to support the regenerating tissue.
- the granulation phase and tissue deposition require nutrients supplied by the capillaries. Impairments in wound angiogenesis therefore may lead to chronic problem wounds.
- angiogenic phenotype is a complex process that requires a number of cellular and molecular events to occur in sequential steps. Some of these activities include endothelial cell proliferation, degradation of surrounding basement membrane, migration of endothelial cells through the connective tissue stroma, formation of tube-like structures, and maturation of endothelial-lined tubes into new blood vessels.
- Angiogenesis is controlled by positive and reduced regulators.
- cells associated with tissue repair such as platelets, monocytes, and macrophages, release angiogenic growth factors, such as vascular endothelial growth factor (VEGF) into injured sites that initiate angiogenesis.
- VEGF vascular endothelial growth factor
- Reduced pressure therapy generally refers to application of a pressure less than the ambient pressure at the wound site, where the magnitude and time period of the reduced pressure treatment is sufficient to promote healing.
- devices used to apply reduced pressure include those popularized by Kinetic Concepts, Inc. of San Antonio, Tex., by its commercially available VACUUM ASSISTED CLOSURE® or V.A.C.® product line.
- the reduced pressure induced healing process has been described in U.S. Pat. Nos. 5,636,643 and 5,645,081, the disclosures of which are incorporated fully by reference.
- the reduced pressure serves to promote the migration of epithelial tissue and subcutaneous tissue from the healthy tissue towards the wound site.
- Typical reduced pressure therapy includes application of reduced pressure to a wound site through a dressing that serves as a manifold to distribute the reduced pressure.
- the dressing is sized to fit the existing wound, placed in contact with the wound, and then periodically replaced with smaller pieces of dressing as the wound begins to heal and becomes smaller. While use of reduced pressure therapy with the dressing has been highly successful, there still exists various difficulties with this process. For example, it may be difficult to obtain a dressing of a proper width, length or depth to properly fit the wound. Further, as the dressing is removed it may also remove healthy tissue, thereby causing further trauma to the wound site.
- biodegradable materials to make the dressing, thereby resulting in a dressing that need not be removed from the wound site.
- biodegradable polymer is formed in advance into a particular shape. Individual wounds, however, are of inconsistent shapes and sizes.
- bioresorbable dressing containing open cell pores where the dressing is designed to readily conform to the size and shape of the wound site.
- the invention produces methods, systems and compositions for making and using porous bioresorbable dressing in various configurations.
- One embodiment in accordance with the invention is a method and apparatus for making a porous bioresorbable dressing to be used at a wound site undergoing reduced pressure therapy, whereby the pore formation occurs in situ.
- a bioresorbable polymer is dissolved in an appropriate solvent and mixed with stoichiometric amounts of a porogen. Residual solvent is removed.
- the resulting dressing is then placed into the wound by being hand molded to fill the shape and size of the wound.
- the resulting dressing may be shaped into a rope which is then coiled into or onto the wound site to fit the shape and size of the wound.
- the wound fluids react with the porogen in the dressing, creating pores within the dressing in situ.
- a drape for sealing the dressing is placed over the dressing at the wound site.
- a reduced pressure delivery tube is fluidly connected to the dressing to deliver a reduced pressure to the wound site.
- Another embodiment in accordance with the invention is a method and apparatus for making a porous bioresorbable dressing to be used at a wound site undergoing reduced pressure therapy.
- a bioresorbable polymer is dissolved in an appropriate solvent and mixed with stoichiometric amounts of porogen. Residual solvent is removed.
- the dressing is then placed in a fluid, whereby the fluid reacts with the porogen in the dressing, creating pores within the dressing.
- the resulting dressing is then dried and placed into the wound site by being hand molded to the shape and size of the wound site.
- the resulting dressing may be shaped into a rope which is then coiled into the wound to fit the shape and size of the wound.
- a drape for sealing the dressing is placed over the dressing at the wound site.
- a reduced pressure delivery tube is fluidly connected to the dressing to deliver a reduced pressure to the wound site.
- Another embodiment in accordance with the invention is a method and apparatus for making a porous bioresorbable dressing to be used at a wound site undergoing reduced pressure therapy, whereby the pore formation occurs in situ.
- a bioresorbable polymer and plasticizer are dissolved in an appropriate solvent and mixed with a porogen.
- the resultant mixture is then contacted with a non-solvent such that the whole mixture will precipitate out of solution as one dressing.
- the residual non-solvent is removed.
- the resulting dressing is placed into the wound site by being hand molded to the shape and size of the wound.
- the resulting dressing may be shaped into a rope that is then coiled into the wound to fit the shape and size of the wound.
- the wound fluids react with the porogen within the dressing, creating pores within the dressing in situ.
- a drape for sealing the dressing is placed over the dressing at the wound site.
- a reduced pressure delivery tube is fluidly connected to the dressing to delivery a reduced pressure to the wound site.
- Another embodiment in accordance with the invention is a method and apparatus for making a porous bioresorbable dressing to be used at a wound site undergoing reduced pressure therapy.
- a bioresorbable polymer and plasticizer are dissolved in an appropriate solvent and mixed with a porogen.
- the resulting mixture is then placed in a non-solvent.
- the non-solvent should be one that results in the polymer, plasticizer and the porogen precipitating out of solution.
- the residual non-solvent is removed.
- the resulting precipitant, i.e., dressing is placed in a fluid, whereby the fluid reacts with the porogen in the dressing, creating pores within the dressing.
- the resulting dressing is then dried and placed into the wound by being hand molded to the shape and size of the wound site.
- the resulting dressing may be shaped into a rope which is then coiled into or onto the wound to fit the shape and size of the wound site.
- a drape for sealing the dressing is placed over the dressing at the wound site.
- a reduced pressure delivery tube is fluidly connected to the dressing to deliver a reduced pressure to the wound site.
- One embodiment in accordance with the invention is a method and apparatus for making a porous bioresorbable dressing to be used at a wound site undergoing reduced pressure therapy where the dressing also contains factors to promote tissue growth and/or healing.
- a bioresorbable polymer is dissolved in an appropriate solvent and mixed with stoichiometric amounts of a porogen. Residual solvent is removed.
- the resulting dressing is then placed into a fluid, whereby the fluid reacts with the porogen in the dressing, creating pores within the dressing. Once the reaction is complete, the dressing is removed from the fluid and allowed to dry.
- the resulting porous dressing may be coated with various substances, including but not limited to, cells, growth factors, or other nutrients that promote cell growth and/or healing.
- the porous dressing is then placed into the wound site by being hand molded to the shape and size of the wound.
- the resulting dressing may be shaped into a rope that is then coiled into or onto the wound to fit the shape and size of the wound site.
- a drape for sealing the dressing is placed over the dressing at the wound site.
- a reduced pressure delivery tube is fluidly connected to the dressing to deliver a reduced pressure to the wound site.
- FIG. 1 illustrates a flowchart in accordance with some embodiments of the invention, demonstrating the process of making a bioresorbable polymer with a sodium biocarbonate and acid porogen system and its use in reduced pressure therapy.
- FIG. 2 illustrates a flowchart in accordance with some embodiments of the invention, demonstrating the process of making a bioresorbable polymer with a salt porogen system and its use in reduced pressure therapy.
- FIG. 3 illustrates a flowchart in accordance with some embodiments of the invention, demonstrating the process of making a porous dressing by use of a bioresorbable polymer and porogen system, and use of the porous dressing in reduced pressure therapy.
- FIG. 4 illustrates a flowchart in accordance with some embodiments of the invention, demonstrating the process of making a porous dressing by use of a bioresorbable polymer and porogen system, and use of the porous dressing in reduced pressure therapy.
- FIG. 5 illustrates a flowchart in accordance with some embodiments of the invention, demonstrating the process of making a porous dressing in the shape of a rope and use of the porous dressing in reduced pressure therapy.
- All embodiments of the invention include use of a bioresorbable dressing to be used in conjunction with reduced pressure therapy for treatment of a wound site.
- the invention is not necessarily limited by a specific location of the wound site, nor the type of tissue that is the target of reduced pressure therapy.
- the wound site treated by the instant invention may be a location upon or within the body in which it is desired to promote growth and/or healing of the tissue.
- the first embodiment in accordance with the invention is to a method and apparatus for preparing a bioresorbable porous polymer dressing and use of the dressing with reduced pressure therapy, as illustrated in FIG. 1 .
- one or more bioresorbable polymers is dissolved in an appropriate solvent ( 101 ).
- the type of solvent used will depend upon the bioresorbable polymer(s) selected.
- the bioresorbable polymer is a biocompatible material whose degradation by products can be bio assimilated or excreted via natural pathways in the body.
- the bioresorbable polymer may include, but is not limited to, lactide, poly(lactide) (PLA), glycolide polymers, poly(glycolic acid) (PGA), poly(lactide-co-glycolide) (PLGA), ethylene glycol/lactide copolymers, polycaprolactone, polyhydroxybutyrate, polyurethanes, polyphosphazenes, poly(ethylene glycol)-poly(lactide-co-glycolide) co-polymer, polyhydroxyacids, polycarbonates, polyamides, polyanhydrides, polyamino acids, polyortho esters, polyacetals, degradable polycyanoacrylates, polycarbonates, polyfumarates, degradable polyurethanes, proteins such as albumin, collagen, fibrin, synthetic and natural polyamino acids, polysaccharides such as alginate, heparin, and other naturally occurring biodegradable polymers of sugar units.
- lactide poly(l
- the polymer is a PLA:PCL copolymer, wherein the ratio of PLA to PCL may range from 100:0 to 0:100. In some preferred embodiments, the PLA:PCL copolymer ratio is about 90:10. In other embodiments, the PLA:PCL copolymer ratio is about 80:20. In yet another embodiment, the PLA:PCL copolymer ratio is about 70:30.
- a porogen system of sodium biocarbonate and acid is also added to the bioresorbable polymer mixture ( 102 ).
- the acid may be any acid that is not in liquid or gaseous form, thus it is in a solid or crystalline state. Examples of appropriate acids to use therein includes, but is not limited to, citric acid.
- the amount of sodium bicarbonate and acid used may be used in stoichiometic amounts. It is also envisioned that the sodium bicarbonate may be used in non stoichiometric amounts. Further, the amount of porogen used should be that which creates sufficient number of open cells or channels so that would fluids may be drained and the reduced pressure may continue unimpaired.
- the solvent is then removed from the resulting dressing ( 103 ).
- methods to remove the solvent include, but are not limited to, evaporation, oven drying, vacuum drying, hand kneading and the like.
- the solvent is evaporated over a period of about 48 hours.
- the dressing may be heat pressed to compress it and remove any residual bubbles that may exist.
- the plates of the hot press are preferably covered or coated with a material that inhibits the sticking of the dressing to the plates. Examples of appropriate materials include, for example, Teflon.
- the practitioner may cover the top and/or bottom plate(s) of the hot press with additional sodium bicarbonate and acid.
- the bottom surface of the dressing is coated with sodium bicarbonate and acid particles with a size of greater than about 500 ⁇ m and/or the top surface of the dressing is coated with sodium bicarbonate and acid particles with a size of about 90 to about 250 ⁇ m.
- an imprinting wafer as the top and/or bottom plate(s) to imprint pores, lines, or other design onto the top and bottom of the dressing.
- the dressing is heat pressed at a given temperature and pressure, then cooled.
- the dressing should be malleable.
- the dressing may be placed in the wound site by use of, for example, hand molding the dressing to fit the shape and size of the wound site ( 104 ).
- the reduced pressure therapy device is then fluidly connected to the wound site ( 105 ).
- the wound site and the dressing are covered by a drape made of a flexible substance.
- the drape is impermeable, thus blocking or slowing the transmission of either liquids or gas.
- the drape is made of a material that permits the diffusion of water vapor but provides an air-tight seal over the wound site when reduced pressure therapy is applied.
- the drape will extend over the surface of the wound site and dressing and extend beyond the edges of the wound.
- the drape is secured to the skin surface about the wound circumference by, for example, adhesive material.
- At least one reduced pressure delivery tube is placed beneath the drape, and extends out from underneath the drape.
- the reduced pressure delivery tube may be made of any medical-grade tubing material, including without limitation, paralyne-coated silicone or urethane. Further, the tubing may be coated with agents to prevent the tubing adhesion to the wound. For example, the tubing may be coated with heparin, anti-coagulants, anti-fibrogens, anti-adherents, anti-thrombinogens or hydrophilic substances.
- the reduced pressure delivery tube is placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- the dressing serves as a manifold to distribute the reduced pressure, assisting in applying reduced pressure to, delivering fluids to, or removing fluids from a wound site.
- the bioresorbable dressing is placed within the wound site and a manifold is placed over the dressing.
- the manifold facilitates even reduced pressure distribution over the entire wound site.
- the wound site, dressing and manifold are then covered by a drape made of impermeable substance that is flexible.
- the drape will extend over the surface of the wound site, dressing and manifold, extending beyond the edges of the wound and preferably secured to the skin surface.
- At least one reduced pressure delivery tube is fluidly connected to the manifold.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- Wound fluids from the wound site then initiate an acid base reaction between the sodium bicarbonate and the acid, producing carbon dioxide gas ( 106 ).
- the carbon dioxide gas production will thus transform the dressing in situ into a three-dimensional structure with interconnected pores, or a “scaffold.” Further, fluids such as water may be added to the wound site to assist in the porogen system reaction.
- step ( 106 ) may occur before step ( 105 ).
- the pore size produced by the carbon dioxide gas production is about 50 to about 1,500 microns. In one embodiment, the pore size is between about 100 and about 500 microns. In another embodiment, the pore size is between about 100 and about 250 microns. It is understood that the size of the resulting pores is dependent upon the size of the sodium bicarbonate and acid particles and the amount of gas produced. As such, one may use any method to control the size of the sodium bicarbonate and acid particles, including by not limited to, sieving and centrifugation. In one embodiment, the sodium bicarbonate and acid are sieved through one or more screens to produce particles of a certain size. Thus, the pore size will be at a minimum the size of the particles produced by the sieving. If the dressing is malleable enough, the carbon dioxide gas produced will further increase the pore size.
- the amount of porogen system used and the particle size of the porogen system will control the percent porosity of the resulting porous dressing. It is understood that the percent porosity preferred by the practitioner may depend upon factors such as the mechanical properties of the materials used within the dressing, such as bioresorbable polymers, the cell infiltration desired, the presence or absence of wound healing or tissue treatment substances, and the like. In one preferred embodiment, the percent porosity is at least about 50%. In another preferred embodiment, the percent porosity is about 70%.
- Reduced pressure therapy is then applied to the wound ( 107 ). It is understood that the frequency of reduced pressure treatment depends upon the location of the body, the size and shape of the wound site, the exact dressing or dressing used, and the types of various agents applied to the site, if any. Further, depending upon the treatment regiment, reduced pressure therapy may be substantially continuous application or cyclical such that it oscillates the pressure over time. As the wound heals, the porous dressing is resorbed by the body and is replaced by granulating tissue.
- plasticizers is added to the bioresorbable polymer in the solvent ( 102 ).
- Plasticizers may be any material that enhances the deformability of a polymeric compound, adding softening and flexibility to the compound.
- the plasticizers may include, but are not limited to, cetyl alcohol esters, glycerol, glycerol esters, acetylated glycerides, glycerol monostearate, glyceryl triacetate, glycerol tributyrate, phthalates, dibutyl phthalate, diethyl phthalate, dimethyl phthalate, dioctyl phthalate, citrates, acetyl tributyl citrate, acetyl triethyl citrate, tributyl citrate, triethyl citrate, sebacates, diethyl sebacate, dibutyl sebacate, adipates, azelates, benzoates, vegetable oils,
- the second embodiment in accordance with the invention is to a method and apparatus for preparing a bioresorbable porous polymer dressing and use of the porous dressing for reduced pressure therapy, as illustrated in FIG. 2 .
- a bioresorbable polymer is dissolved in an appropriate solvent ( 201 ).
- the bioresorbable polymer may be made of one or more polymers that are bioresorbable. Suitable polymer include those polymers disclosed in other embodiments of the invention. In an alternate embodiment, one or more plasticizers are also added to the bioresorbable polymer.
- the bioresorbable polymer is then mixed with a crystalline or solid salt that serves as the porogen system ( 202 ).
- the invention is not limited by the type of salt, as long as the salt is of an appropriate particle size and dissolvable in a fluid, i.e., a gas, liquid, or flowable material, including but not limited to, colloids, dressings, a liquid, a slurry, a suspension, a viscous gel, a paste, a putty, and particulate solids.
- a fluid i.e., a gas, liquid, or flowable material
- colloids i.e., colloids, dressings, a liquid, a slurry, a suspension, a viscous gel, a paste, a putty, and particulate solids.
- appropriate salts used herein includes, but is not limited to, sodium chloride and potassium chloride.
- the amount of salt used may be used in stoichiometic amounts. It is also envisioned
- the solvent is then removed ( 203 ).
- methods to remove the solvent include, but are not limited to, evaporation, oven drying, vacuum drying, hand kneading and the like.
- the solvent is evaporated over a period of about 48 hours.
- the resulting dressing may be heat pressed to compress the dressing and remove any residual bubbles that may exist.
- the plates of the hot press are preferably covered or coated with a material that inhibits the sticking of the dressing to the plates. Examples of appropriate materials include, for example, Teflon.
- the practitioner may cover the top and/or bottom plate(s) of the hot press with additional particles of the salt, i.e., the porogen system.
- the bottom surface of the dressing is coated with salt particles of a size of greater than about 500 ⁇ m and the top surface of the dressing is coated with salt particles with a size of about 90 to about 250 ⁇ m.
- an imprinting wafer as the top and/or bottom plate(s) to imprint pores, lines, or other design onto the top and bottom of the dressing. The dressing is pressed at a given temperature and pressure, then cooled.
- the dressing should be malleable. As such, one may place the dressing in the wound site by use of, for example, hand molding the dressing in the wound site to fill the shape and size of the wound ( 204 ).
- the reduced pressure device is then fluidly connected to the wound site ( 205 ).
- the wound site and the dressing are covered by a drape made of impermeable substance that is flexible.
- the drape is made of a material that permits the diffusion of water vapor but provides an air-tight enclosure.
- the drape will extend over the surface of the wound site and dressing and extend beyond the edges of the wound.
- the drape is secured to the skin surface about the wound circumference by, for example, adhesive material.
- At least one reduced pressure delivery tube is placed beneath the drape, and extends out from underneath the drape.
- the reduced pressure delivery tube may be made of any medical-grade tubing material, including without limitation paralyne-coated silicone or urethane.
- the tubing may be coated with agents to prevent the tubing adhesion to the wound.
- the tubing may be coated with heparin, anti-coagulants, anti-fibrogens, anti-adherents, anti-thrombinogens or hydrophilic substances.
- the dressing serves as a manifold to distribute the reduced pressure.
- the bioresorbable dressing is placed within the wound site and a manifold is placed over the dressing.
- the manifold facilitates even reduced pressure distribution over the entire wound site.
- the wound site, dressing and manifold are then covered by a drape made of impermeable substance that is flexible.
- the drape will extend over the surface of the wound site, dressing and manifold, extending beyond the edges of the wound and preferably secured to the skin surface.
- At least one reduced pressure delivery tube is fluidly connected to the manifold.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- Wound fluids which may include interstitial liquid in the tissues or liquid that has exuded from the tissue or its capillaries of the wound site, will then react with the porogen system, dissolving the salt particles and thus generating pores within the dressing in situ ( 206 ). Further, fluids such as water may be added to the wound site to assist in the porogen system reaction.
- the resulting spaces left by the dissolved salt result in a dressing with interconnected pores.
- the size of the resulting pores is dependent upon the size of the salt particles used. As such, one may use methods to control the size of the salt particles.
- the salt particles may be sieved through one or more screens to produce particles of a certain size. When the salt particle dissolves, the remaining pore is about the size of the salt particle.
- the pore size produced by the dissolved salt may be about 50 to about 500 microns. In another embodiment, the pore size is between about 100 and about 400 microns. In another embodiment, the pore size is between about 100 and about 250 microns.
- the amount of porogen system used and the particle size of the porogen system will control the percent porosity. It is understood that the percent porosity preferred may depend upon factors such as the mechanical properties of the materials used to make the dressing, the cell infiltration desired, the presence or absence of wound healing or tissue treatment substances trapped within or bound to the dressing, and the like.
- Wound healing or tissue treatment substances may be covalently or non-covalently bound to dressing by, for example, use of a cross linker, inclusion of a specific reactive group on either the solid support or the s or both molecules, electrostatic interactions, hydrophilic interactions, hydrophobic interactions, attachment by use of molecules such as streptavidin, and use of a combination of covalent and non-covalent interactions.
- the percent porosity is at least about 50%. In another preferred embodiment, the percent porosity is about 70%.
- step ( 206 ) may occur before step ( 205 ).
- Reduced pressure therapy is then applied to the wound ( 207 ).
- the wound heals the dressing is resorbed by the body and is replaced by granulating tissue.
- one or more plasticizers is added to the bioresorbable polymer in the solvent ( 202 ). If one or more plasticizers are included in the polymer, then the residual solvent may be removed ( 203 ) by any method such as oven drying or vacuum drying as long as the conditions used do not favor evaporation of the plasticizer.
- the third embodiment in accordance with the invention is to a method and apparatus for preparing a bioresorbable porous polymer dressing and use of the dressing for reduced pressure therapy, as illustrated in FIG. 3 .
- bioresorbable polymers are dissolved in an appropriate solvent ( 301 ).
- Suitable bioresorbable polymers may include any polymers discussed in other embodiments of the invention.
- at least one plasticizer is also added to the bioresorbable polymer.
- the bioresorbable polymer is then mixed with a porogen system, which may include one or more compounds that result in creation of pores within the dressing.
- a porogen system is not limited, and may include compounds that dissolve when placed in contact with a fluid.
- This type of porogen system includes inorganic salts like sodium chloride, crystals of saccharose, or gelatin spheres will dissolve in fluids such as water.
- Another type of porogen system is a mixture of sodium bicarbonate and an acid. Sodium bicarbonate and acid, when placed in contact with a fluid, result in the bicarbonate and acid reacting to form carbon dioxide gas. The gas may then increase the size of the pores.
- the solvent is then removed, leaving behind a dressing ( 303 ).
- methods to remove the solvent include, but are not limited to, evaporation, oven drying, vacuum drying, hand kneading and the like.
- the dressing may be heat pressed to compress the dressing and remove any residual bubbles that may exist.
- the plates of the hot press are preferably covered or coated with a material that inhibits the sticking of the dressing to the plates, for example, Teflon.
- Teflon Teflon
- the practitioner may cover the top and/or bottom plate(s) of the hot press with additional porogen system particles.
- the bottom surface of the dressing is coated with porogen system particles of a size of greater than about 500 ⁇ m and the top surface of the dressing is coated with porogen system particles with a size of about 90 to about 250 ⁇ m.
- an imprinting wafer as the top and/or bottom plate(s) to imprint pores, lines, or other design onto the top and bottom of the dressing. The dressing is pressed at a given temperature and pressure, and then the dressing is cooled
- the dressing is then placed in warm water to increase its malleability and react the porogen system, thereby initiating the creation of pores ( 304 ).
- the resulting spaces left by the porogen system result in the dressing being a dressing with interconnected pores.
- the size of the resulting pores is dependent upon the size of the porogen particles used. As such, one may use means to control the porogen particle size by use of, for example, sieving the particles with screens. Further, the amount of porogen system used and the particle size of the porogen system will control the percent porosity. In one preferred embodiment, the percent porosity is at least about 50%. In another preferred embodiment, the percent porosity is about 70%.
- one or more substances may be used to coat the porous dressing or may be bound to the porous dressing.
- the dressing may be coated with collagen, hyaluronic acid, gelatin chitosan, antimicrobial agents, therapeutic agents, antiviral agents, growth factors, bioactive substances and other agents that may further facilitate healing and/or tissue growth.
- the dressing may be coated with a substance to make the dressing radiopaque.
- the dressing is soaked in a solution containing collagen. The dressing is then drained of excess solution and lyophilization of the dressing occurs.
- the dressing is soaked in a solution containing collagen, drained of excess solution and the collagen is then crosslinked onto the dressing.
- the dressing is then placed in the wound site by use of hand molding the dressing in the wound site to fill the shape and size of the wound ( 305 ).
- the dressing is cut to fit the size and shape of the wound. Any wound fluids from the wound site may also act on any remaining porogen system to create further pores.
- the reduced pressure device is then fluidly connected to the wound site ( 306 ).
- the wound site and the dressing are covered by a drape made of impermeable substance that is flexible.
- the drape is made of a material that permits the diffusion of water vapor but provides an air-tight enclosure.
- the drape will extend over the surface of the wound site and dressing and extend beyond the edges of the wound.
- the drape is secured to the skin surface about the wound circumference by, for example, adhesive material.
- At least one reduced pressure delivery tube is placed beneath the drape, and extends out from underneath the drape.
- the reduced pressure delivery tube may be made of any medical-grade tubing material, including without limitation paralyne-coated silicone or urethane. Further, the tubing may be coated with agents to prevent the tubing adhesion to the wound.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- the dressing serves as a manifold to
- a manifold is placed over the bioresorbable dressing.
- the manifold facilitates even reduced pressure distribution over the entire wound site.
- the reduced pressure delivery tube is then fluidly connected to the manifold.
- Reduced pressure therapy is then applied to the wound ( 307 ).
- the wound heals the dressing is resorbed by the body and is replaced by granulating tissue.
- the fourth embodiment in accordance with the invention is to a method and apparatus for preparing a bioresorbable porous polymer and use of the polymer as a dressing for reduced pressure therapy, as illustrated in FIG. 4 .
- a bioresorbable polymer is dissolved in an appropriate solvent ( 401 ).
- Suitable bioresorbable polymers include, but are not limited to, polymers disclosed in the other embodiments of the invention.
- the bioresorbable polymer is then mixed with one or more plasticizers and a porogen system to form a non-solid mixture, such as a fluid or a slurry ( 402 ).
- the porogen system may include but is not limited to, a dissolvable salt or a combination of sodium bicarbonate and acid.
- the amount of porogen system used may be used in stoichiometic amounts. It is also envisioned that the porogen system may be in non stoichiometric amounts.
- the resulting mixture is then added to a non-solvent for the polymer, plasticizer and porogen such that the mixture precipitates out of solution when the mixture comes in contact with the non-solvent ( 403 ).
- Excess non-solvent is then removed from the resulting precipitate ( 404 ).
- methods to remove the non solvent includes, but is not limited to, evaporation, hand kneading, and the like. Residual solvent may be removed by any method such as oven drying or vacuum driving as long as the conditions used do not favor evaporation of the plasticizer.
- the resulting dressing may also be heat pressed to remove any residual bubbles that may exist.
- the resulting dressing should be malleable.
- the dressing can be molded to fill the shape and size of the wound.
- the dressing is shaped by rolling the dressing into a sheet of a desired thickness and cutting the dressing into the desired shape and size of the wound.
- the reduced pressure device is then fluidly connected to the wound site ( 406 ).
- the wound site and the dressing are covered by a drape made of impermeable substance that is flexible.
- the drape is made of a material that permits the diffusion of water vapor but provides an air-tight enclosure.
- the drape will extend over the surface of the wound site and dressing and extend beyond the edges of the wound, where it is secured to the skin surface by, for example, adhesive material.
- At least one reduced pressure delivery tube is placed beneath the drape, and extends out from underneath the drape.
- the reduced pressure delivery tube may be made of any medical-grade tubing material and may be coated with agents to prevent the tubing adhesion to the wound.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- the dressing serves to distribute the reduced pressure.
- the bioresorbable dressing is placed within the wound site and a manifold is placed over the dressing.
- the manifold facilitates even reduced pressure distribution over the entire wound site.
- the wound site, dressing and manifold are then covered by a drape made of impermeable substance that is flexible.
- the drape will extend over the surface of the wound site, dressing and manifold, extending beyond the edges of the wound and preferably secured to the skin surface.
- At least one reduced pressure delivery tube is fluidly connected to the manifold.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- Wound fluids from the wound site will then react with the porogen system, forming pores in situ ( 407 ).
- the resulting spaces left by the porogen system result in a scaffold, i.e., dressing with interconnected pores.
- the size of the resulting pores is dependent upon the size of the porogen particles used. As such, one may use means to control the porogen particle size by use of, for example, sieving the particles with screens. Further, the amount of porogen system used and the particle size of the porogen system will control the percent porosity. In one preferred embodiment, the percent porosity is at least about 50%. In another preferred embodiment, the percent porosity is about 70%.
- the porogen system is placed in contact with a fluid before step ( 406 ) such that the porogen system reacts with the fluid and forms the interconnected pores before the dressing, i.e., scaffold, is placed in the wound site.
- Reduced pressure therapy is then applied to the wound ( 408 ).
- the dressing is resorbed by the body and is replaced by granulating tissue.
- a porous, bioresorbable rope dressing or dressing is prepared that can be placed into a wound of any size, shape or depth and be able to fill the wound completely because of its rope configuration and flexibility, as illustrated in FIG. 5 .
- the shape of the rope may be non-woven, woven, knitted, braided polymer fibers and the like. These different shapes introduce additional channels or pockets of air, and are based upon the shape of the polymer fibers and the degree of their interwoven nature.
- a bioresorbable polymer is dissolved in an appropriate solvent ( 501 ).
- Suitable polymers include, but are not limited to, polymers disclosed in the other embodiments of the invention.
- the bioresorbable polymer is then mixed with one or more plasticizers and a porogen system to form a non-solid mixture, such as a fluid or slurry ( 502 ).
- the porogen system may include but is not limited to, a dissolvable salt or a combination of sodium bicarbonate and acid.
- the amount of porogen system used may be used in stoichiometic amounts or non stoichiometric amounts.
- the resulting mixture is then extruded through a syringe or other device with a desired tip diameter into a non solvent for the polymer, plasticizer and porogen such that the mixture precipitates out of solution in the form of a string or rope ( 503 ).
- the rope may be shaped by rolling the resulting mixture into a sheet of a desired thickness and cutting the dressing into a rope shape.
- the rope dressing is then transferred to an aqueous medium such as water to react with the porogen system and therefore form a porous dressing ( 504 ).
- the resulting spaces left by the porogen system result in a dressing with interconnected pores.
- the size of the resulting pores is dependent upon the size of the porogen particles used. As such, one may use means to control the porogen particle size by use of, for example, sieving the particles with screens. Further, the amount of porogen system used and the particle size of the porogen system will control the percent porosity. In one preferred embodiment, the percent porosity is at least about 50%. In another preferred embodiment, the percent porosity is about 70%.
- the excess medium is then removed by means including, but not limited to evaporation, hand kneading and the like ( 505 ). Further, oven drying or vacuum drying may also be used as long as the conditions used do not favor evaporation of the plasticizer. If necessary, the rope-shaped dressing may also be heat pressed to remove any residual bubbles that may exist.
- the resulting dressing should be malleable.
- the rope-shaped dressing can be coiled into the wound site to fill the shape and size of the wound ( 506 ).
- two or more ropes are braided or twisted together to form a thicker diameter rope that is then coiled into the wound site.
- a reduced pressure device is then fluidly connected to the wound site ( 507 ).
- the wound site and the dressing are covered by a drape made of impermeable substance that is flexible.
- the drape is made of a material that permits the diffusion of water vapor but provides an air-tight enclosure.
- the drape will extend over the surface of the wound site and dressing and extend beyond the edges of the wound.
- the drape is secured to the skin surface about the wound circumference by, for example, adhesive material.
- At least one reduced pressure delivery tube is placed beneath the drape, and extends out from underneath the drape.
- the reduced pressure delivery tube may be made of any medical-grade tubing material and may be coated with agents to prevent the tubing adhesion to the wound.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- the dressing serves to distribute the reduced pressure.
- the bioresorbable dressing is placed within the wound site and a manifold is placed over the dressing.
- the manifold facilitates even reduced pressure distribution over the entire wound site.
- the wound site, dressing and manifold are then covered by a drape made of impermeable substance that is flexible.
- the drape will extend over the surface of the wound site, dressing and manifold, extending beyond the edges of the wound and preferably secured to the skin surface.
- At least one reduced pressure delivery tube is fluidly connected to the manifold.
- the reduced pressure delivery tube is also placed in fluid communication to a reduced pressure source, which preferably comprises a canister safely placed under the vacuum through fluid communication with a reduced pressure source.
- Wound fluids from the wound site react with any residual porogen system, and form additional pores in situ ( 508 ). Reduced pressure therapy is then applied to the wound ( 509 ). As the wound heals, the dressing is resorbed by the body and is replaced by granulating tissue.
- the rope diameter could vary but preferably would be between about 2 to about 7 mm.
- the bioresorbable dressing may be formed by any means suited to the practitioner.
- a porous, bioresorbable dressing is prepared by heating one or more bioresorbable polymers above its glass transition temperature such that the polymer is flowable.
- Suitable polymers include, but are not limited to, polymers disclosed in the other embodiments of the invention.
- the bioresorbable polymer is then mixed with a porogen system.
- one or more plasticizers is also added to the bioresorbable polymer.
- the resulting mixture is stirred, with or without additional heating, until the biodegradable polymer is mixed with the porogen system.
- the mixture may then be formed into a sheet or mold and cooled.
- the resulting mixture may be formed by any means into a shape and size dressing desired to fit the wound site, including but not limited to, hand molding, laser cutting, and the like.
- a porous, bioresorbable interfacial layer was prepared by combining a solution of 2.36 g of 90:10 PLA:PCL and 0.26 g of triethylcitrate in 12 mL of dichloromethane with a mixture of 1.65 g citric acid and 2.73 g sodium bicarbonate that have been sieved to a particle size of 90-250 .
- the suspension was cast onto a Teflon-coated mold and dried.
- the resulting sheet was then hot-pressed, soaked in water for 12 hrs to remove the porogen, and dried.
- V.A.C.® Therapy was simulated using a grid equipped with fluid ports and pressure sensors, a saline infusion rate of 500 mL/day and an applied pressure of 50, 125 or 200 mmHg.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/983,548 US20080114277A1 (en) | 2006-11-09 | 2007-11-09 | Porous bioresorbable dressing conformable to a wound and methods of making same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85790206P | 2006-11-09 | 2006-11-09 | |
US85790306P | 2006-11-09 | 2006-11-09 | |
US85781406P | 2006-11-09 | 2006-11-09 | |
US11/983,548 US20080114277A1 (en) | 2006-11-09 | 2007-11-09 | Porous bioresorbable dressing conformable to a wound and methods of making same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080114277A1 true US20080114277A1 (en) | 2008-05-15 |
Family
ID=39365147
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/983,549 Expired - Fee Related US8110216B2 (en) | 2006-11-09 | 2007-11-09 | Methods of making porous bioresorbable dressing comprising casing comprising microspheres |
US11/983,548 Abandoned US20080114277A1 (en) | 2006-11-09 | 2007-11-09 | Porous bioresorbable dressing conformable to a wound and methods of making same |
US13/355,266 Active US8273368B2 (en) | 2006-11-09 | 2012-01-20 | Porous bioresorbable linked dressing comprising microspheres and methods of making same |
US13/584,373 Expired - Fee Related US8496959B2 (en) | 2006-11-09 | 2012-08-13 | Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles |
US13/942,382 Active US8852627B2 (en) | 2006-11-09 | 2013-07-15 | Porous bioresorbable rope shaped wound dressing comprising microparticles and reduced pressure source |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/983,549 Expired - Fee Related US8110216B2 (en) | 2006-11-09 | 2007-11-09 | Methods of making porous bioresorbable dressing comprising casing comprising microspheres |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/355,266 Active US8273368B2 (en) | 2006-11-09 | 2012-01-20 | Porous bioresorbable linked dressing comprising microspheres and methods of making same |
US13/584,373 Expired - Fee Related US8496959B2 (en) | 2006-11-09 | 2012-08-13 | Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles |
US13/942,382 Active US8852627B2 (en) | 2006-11-09 | 2013-07-15 | Porous bioresorbable rope shaped wound dressing comprising microparticles and reduced pressure source |
Country Status (14)
Country | Link |
---|---|
US (5) | US8110216B2 (ko) |
EP (3) | EP2783665B1 (ko) |
JP (3) | JP5850516B2 (ko) |
KR (2) | KR20090082468A (ko) |
CN (3) | CN101534762B (ko) |
AU (2) | AU2007319939B2 (ko) |
CA (2) | CA2663774C (ko) |
HK (1) | HK1134008A1 (ko) |
IL (2) | IL198584A0 (ko) |
NO (2) | NO20092082L (ko) |
SG (1) | SG175690A1 (ko) |
TW (2) | TWI362925B (ko) |
WO (2) | WO2008057600A2 (ko) |
ZA (1) | ZA200902780B (ko) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070219489A1 (en) * | 2006-03-14 | 2007-09-20 | Johnson Royce W | Method for percutaneously administering reduced pressure treatment using balloon dissection |
US20090157017A1 (en) * | 2006-03-14 | 2009-06-18 | Archel Ambrosio | Bioresorbable foaming tissue dressing |
US20100297208A1 (en) * | 2006-05-12 | 2010-11-25 | Nicholas Fry | Scaffold |
US20110184357A1 (en) * | 2010-01-22 | 2011-07-28 | Kci Licensing, Inc. | Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy |
US20120150188A1 (en) * | 2009-04-17 | 2012-06-14 | Mccarthy Stephen | Absorbable bone adhesive applicator |
US8235939B2 (en) | 2006-02-06 | 2012-08-07 | Kci Licensing, Inc. | System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment |
WO2012142473A1 (en) * | 2011-04-15 | 2012-10-18 | University Of Massachusetts | Surgical cavity drainage and closure system |
US8939933B2 (en) | 2006-03-14 | 2015-01-27 | Kci Licensing, Inc. | Manifolds, systems, and methods for administering reduced pressure to a subcutaneous tissue site |
US9259228B2 (en) | 2006-06-15 | 2016-02-16 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9351993B2 (en) | 2012-06-14 | 2016-05-31 | Microvention, Inc. | Polymeric treatment compositions |
US9370536B2 (en) | 2012-09-26 | 2016-06-21 | Lifecell Corporation | Processed adipose tissue |
US9381278B2 (en) | 2012-04-18 | 2016-07-05 | Microvention, Inc. | Embolic devices |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US9486221B2 (en) | 2007-12-21 | 2016-11-08 | Microvision, Inc. | Hydrogel filaments for biomedical uses |
US9655989B2 (en) | 2012-10-15 | 2017-05-23 | Microvention, Inc. | Polymeric treatment compositions |
US9993252B2 (en) | 2009-10-26 | 2018-06-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
US20180325741A1 (en) * | 2017-05-15 | 2018-11-15 | Baxter International Inc. | Biodegradable negative pressure wound therapy dressing |
US10226533B2 (en) | 2014-04-29 | 2019-03-12 | Microvention, Inc. | Polymer filaments including pharmaceutical agents and delivering same |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
US10576182B2 (en) | 2017-10-09 | 2020-03-03 | Microvention, Inc. | Radioactive liquid embolic |
US10639398B2 (en) | 2016-07-05 | 2020-05-05 | Lifecell Corporation | Tissue matrices incorporating multiple tissue types |
US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
US10821205B2 (en) | 2017-10-18 | 2020-11-03 | Lifecell Corporation | Adipose tissue products and methods of production |
US11090338B2 (en) | 2012-07-13 | 2021-08-17 | Lifecell Corporation | Methods for improved treatment of adipose tissue |
CN113303974A (zh) * | 2021-05-26 | 2021-08-27 | 华中科技大学同济医学院附属协和医院 | 新型无菌压疮敷料及其制造方法 |
US11123375B2 (en) | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
CN114533935A (zh) * | 2022-02-28 | 2022-05-27 | 浙江卫未生物医药科技有限公司 | 一种用于解决青春痘的细胞因子敷料及其制备方法 |
US11633521B2 (en) | 2019-05-30 | 2023-04-25 | Lifecell Corporation | Biologic breast implant |
US11826488B2 (en) | 2017-10-19 | 2023-11-28 | Lifecell Corporation | Flowable acellular tissue matrix products and methods of production |
US11957814B2 (en) | 2011-05-31 | 2024-04-16 | Lifecell Corporation | Adipose tissue matrices |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4636634B2 (ja) | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 脈管内ステント |
EP1663380B1 (en) | 2003-07-22 | 2012-02-29 | KCI Licensing, Inc. | Negative pressure wound treatment dressing |
ES2804472T3 (es) | 2005-12-13 | 2021-02-08 | Harvard College | Estructuras para trasplante celular |
CN101534762B (zh) | 2006-11-09 | 2012-09-05 | 凯希特许有限公司 | 适合伤口的多孔生物可吸收敷料及其制备方法 |
EP3335680A1 (en) | 2007-02-09 | 2018-06-20 | KCI Licensing, Inc. | A breathable interface system for topical reduced pressure |
US9770535B2 (en) | 2007-06-21 | 2017-09-26 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
HUE043133T2 (hu) | 2007-11-21 | 2019-07-29 | Smith & Nephew | Sebkötözés |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
EP2987510B1 (en) | 2007-11-21 | 2020-10-28 | T.J. Smith & Nephew Limited | Suction device and dressing |
GB0723875D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound management |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US8377017B2 (en) | 2008-01-03 | 2013-02-19 | Kci Licensing, Inc. | Low-profile reduced pressure treatment system |
JP5690143B2 (ja) | 2008-02-13 | 2015-03-25 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 持続的細胞プログラミング装置 |
US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
KR20100129765A (ko) | 2008-03-13 | 2010-12-09 | 케이씨아이 라이센싱 인코포레이티드 | 감압을 족부의 조직 부위에 가하는 족부 매니폴드,장치,시스템 및 방법 |
US8685432B2 (en) * | 2008-03-25 | 2014-04-01 | University Of Utah Research Foundation | Controlled release tissue graft combination biomaterials |
WO2011127149A1 (en) * | 2010-04-06 | 2011-10-13 | University Of Utah Research Foundation | Controlled release combination biomaterials |
TW200950824A (en) | 2008-04-30 | 2009-12-16 | Kci Licensing Inc | Use of nucleic acids with reduced pressure therapy |
US8876864B2 (en) * | 2008-06-24 | 2014-11-04 | Bioactive Surgical, Inc | Surgical sutures incorporated with stem cells or other bioactive materials |
JP5337248B2 (ja) * | 2008-09-18 | 2013-11-06 | ケーシーアイ ライセンシング インコーポレイテッド | 炎症反応の抑制システム及び方法 |
US8158844B2 (en) | 2008-10-08 | 2012-04-17 | Kci Licensing, Inc. | Limited-access, reduced-pressure systems and methods |
WO2010051067A1 (en) | 2008-10-29 | 2010-05-06 | Kci Licensing, Inc. | Reduced-pressure, deep-tissue closure systems and methods |
US8529528B2 (en) * | 2008-12-24 | 2013-09-10 | Kci Licensing, Inc. | Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds |
US8708984B2 (en) * | 2008-12-24 | 2014-04-29 | Kci Licensing, Inc. | Reduced-pressure wound treatment systems and methods employing manifold structures |
GB0900423D0 (en) | 2009-01-12 | 2009-02-11 | Smith & Nephew | Negative pressure device |
CA2768552A1 (en) | 2009-07-31 | 2011-02-03 | President And Fellows Of Harvard College | Programming of cells for tolerogenic therapies |
DE102009038387A1 (de) * | 2009-08-24 | 2011-03-03 | Birgit Riesinger | Wundpflegeartikel mit konvexer Einlage |
EP2335661B1 (de) | 2009-12-18 | 2012-12-12 | Paul Hartmann AG | Zuschneidehilfe für Wundauflage zur Unterdrucktherapie |
US8721606B2 (en) * | 2010-03-11 | 2014-05-13 | Kci Licensing, Inc. | Dressings, systems, and methods for treating a tissue site |
US8882730B2 (en) | 2010-03-12 | 2014-11-11 | Kci Licensing, Inc. | Radio opaque, reduced-pressure manifolds, systems, and methods |
US8632512B2 (en) * | 2010-04-09 | 2014-01-21 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
US9999702B2 (en) | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
US8604265B2 (en) * | 2010-04-16 | 2013-12-10 | Kci Licensing, Inc. | Dressings and methods for treating a tissue site on a patient |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
GB201011173D0 (en) | 2010-07-02 | 2010-08-18 | Smith & Nephew | Provision of wound filler |
EP3620185A1 (en) | 2010-10-06 | 2020-03-11 | President and Fellows of Harvard College | Injectable, pore-forming hydrogels for materials-based cell therapies |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
AU2011333538C1 (en) | 2010-11-25 | 2015-07-30 | Bluestar Silicones France Sas | Composition I-II and products and uses thereof |
US8597264B2 (en) | 2011-03-24 | 2013-12-03 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
WO2012149358A1 (en) | 2011-04-28 | 2012-11-01 | President And Fellows Of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
EP2714073B1 (en) | 2011-06-03 | 2021-03-10 | President and Fellows of Harvard College | In situ antigen-generating cancer vaccine |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
EP2809281A1 (en) * | 2012-02-02 | 2014-12-10 | KCI Licensing, Inc. | Foam structure wound inserts for directional granulation |
IN2014DN08122A (ko) | 2012-03-06 | 2015-05-01 | Ferrosan Medical Devices As | |
CN104244929B (zh) | 2012-04-16 | 2017-04-05 | 哈佛学院董事会 | 用于调节免疫反应的介孔二氧化硅组合物 |
RU2636240C2 (ru) | 2012-06-12 | 2017-11-21 | Ферросан Медикал Дивайсиз А/С | Сухая гемостатическая композиция |
US9889235B2 (en) | 2013-02-05 | 2018-02-13 | University Of Utah Research Foundation | Implantable devices for bone or joint defects |
US8893721B2 (en) * | 2013-03-15 | 2014-11-25 | Futrell Medical Corporation | Surgical drape with vapor evacuation |
WO2014151107A1 (en) | 2013-03-15 | 2014-09-25 | Kcl Licensing, Inc. | Wound healing compositions |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
US10111980B2 (en) | 2013-12-11 | 2018-10-30 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
US9770369B2 (en) | 2014-08-08 | 2017-09-26 | Neogenix, Llc | Wound care devices, apparatus, and treatment methods |
AU2015333206B2 (en) | 2014-10-13 | 2019-07-11 | Ferrosan Medical Devices A/S. | Dry composition for use in haemostasis and wound healing |
BR112017013565B1 (pt) | 2014-12-24 | 2021-12-28 | Ferrosan Medical Devices A/S | Seringa para retenção e mistura de primeira e segunda substâncias |
EP3250250A4 (en) | 2015-01-30 | 2019-05-22 | President and Fellows of Harvard College | PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY |
CN114099793A (zh) | 2015-04-10 | 2022-03-01 | 哈佛学院院长等 | 免疫细胞捕获装置及其制备和使用方法 |
BR112017027695A2 (pt) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | seringa para retenção e mistura de primeira e segunda substâncias |
EP3411475A4 (en) | 2016-02-06 | 2019-09-11 | President and Fellows of Harvard College | REGENERATION OF THE HEMATOPOIETIC NICHE TO RECONSTITUTE IMMUNITY |
JP2019522486A (ja) | 2016-07-13 | 2019-08-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗原提示細胞模倣足場およびそれを作製および使用するための方法 |
CN111432761B (zh) | 2017-11-03 | 2022-09-09 | 3M创新知识产权公司 | 延长穿戴时间的敷料 |
WO2019215274A1 (en) | 2018-05-09 | 2019-11-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
US11877916B2 (en) | 2019-05-03 | 2024-01-23 | Parkview Health | Perineal therapy pad |
US20220202620A1 (en) * | 2019-05-08 | 2022-06-30 | Kci Licensing, Inc. | Manifold With Biological Actives For Negative-Pressure Therapy |
CN112587709A (zh) * | 2020-12-25 | 2021-04-02 | 天津强微特生物科技有限公司 | 一种含多重生长因子的3d打印敷料粘带及制备方法 |
Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) * | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) * | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) * | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
US2682873A (en) * | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
US2969057A (en) * | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3367332A (en) * | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) * | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) * | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3648692A (en) * | 1970-12-07 | 1972-03-14 | Parke Davis & Co | Medical-surgical dressing for burns and the like |
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
US3826254A (en) * | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4096853A (en) * | 1975-06-21 | 1978-06-27 | Hoechst Aktiengesellschaft | Device for the introduction of contrast medium into an anus praeter |
US4139004A (en) * | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4165748A (en) * | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4184510A (en) * | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4245630A (en) * | 1976-10-08 | 1981-01-20 | T. J. Smith & Nephew, Ltd. | Tearable composite strip of materials |
US4256109A (en) * | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
US4261363A (en) * | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4275721A (en) * | 1978-11-28 | 1981-06-30 | Landstingens Inkopscentral Lic, Ekonomisk Forening | Vein catheter bandage |
US4284079A (en) * | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4333468A (en) * | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4382441A (en) * | 1978-12-06 | 1983-05-10 | Svedman Paul | Device for treating tissues, for example skin |
US4392853A (en) * | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4392858A (en) * | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4465485A (en) * | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4475909A (en) * | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
US4525374A (en) * | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
US4525166A (en) * | 1981-11-21 | 1985-06-25 | Intermedicat Gmbh | Rolled flexible medical suction drainage device |
US4540412A (en) * | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) * | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4569348A (en) * | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4605399A (en) * | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US4608041A (en) * | 1981-10-14 | 1986-08-26 | Frese Nielsen | Device for treatment of wounds in body tissue of patients by exposure to jets of gas |
US4640688A (en) * | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4664662A (en) * | 1984-08-02 | 1987-05-12 | Smith And Nephew Associated Companies Plc | Wound dressing |
US4733659A (en) * | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
US4743232A (en) * | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
US4758220A (en) * | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4826494A (en) * | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4838883A (en) * | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
US4840187A (en) * | 1986-09-11 | 1989-06-20 | Bard Limited | Sheath applicator |
US4863449A (en) * | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US4897081A (en) * | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US4906233A (en) * | 1986-05-29 | 1990-03-06 | Terumo Kabushiki Kaisha | Method of securing a catheter body to a human skin surface |
US4906240A (en) * | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4919654A (en) * | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US4941882A (en) * | 1987-03-14 | 1990-07-17 | Smith And Nephew Associated Companies, P.L.C. | Adhesive dressing for retaining a cannula on the skin |
US4948575A (en) * | 1989-01-24 | 1990-08-14 | Minnesota Mining And Manufacturing Company | Alginate hydrogel foam wound dressing |
US4953565A (en) * | 1986-11-26 | 1990-09-04 | Shunro Tachibana | Endermic application kits for external medicines |
US4985019A (en) * | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
US5037397A (en) * | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US5086170A (en) * | 1989-01-16 | 1992-02-04 | Roussel Uclaf | Process for the preparation of azabicyclo compounds |
US5092858A (en) * | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5100396A (en) * | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5134994A (en) * | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5149331A (en) * | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5176663A (en) * | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US5215522A (en) * | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
US5232453A (en) * | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
US5278100A (en) * | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5279550A (en) * | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5298015A (en) * | 1989-07-11 | 1994-03-29 | Nippon Zeon Co., Ltd. | Wound dressing having a porous structure |
US5342376A (en) * | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US5344415A (en) * | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437622A (en) * | 1992-04-29 | 1995-08-01 | Laboratoire Hydrex (Sa) | Transparent adhesive dressing with reinforced starter cuts |
US5437651A (en) * | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5525646A (en) * | 1991-03-04 | 1996-06-11 | Lundgren; Dan | Bioresorbable material and an article of manufacture made of such material for medical use |
US5527293A (en) * | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5549584A (en) * | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5556375A (en) * | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) * | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5641502A (en) * | 1995-06-07 | 1997-06-24 | United States Surgical Corporation | Biodegradable moldable surgical material |
US5645081A (en) * | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5716413A (en) * | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
US5766631A (en) * | 1993-09-21 | 1998-06-16 | Arnold; Peter Stuart | Wound implant materials |
US5792469A (en) * | 1992-03-12 | 1998-08-11 | Atrix Laboratories, Inc. | Biodegradable in situ forming film dressing |
US6071267A (en) * | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US6287316B1 (en) * | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US6345523B1 (en) * | 2000-09-29 | 2002-02-12 | Lambert Kuo | Figure wheel of a combination lock |
US20020077661A1 (en) * | 2000-12-20 | 2002-06-20 | Vahid Saadat | Multi-barbed device for retaining tissue in apposition and methods of use |
US20020115951A1 (en) * | 2001-02-22 | 2002-08-22 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US20020120185A1 (en) * | 2000-05-26 | 2002-08-29 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US20030044380A1 (en) * | 2001-07-19 | 2003-03-06 | Zhu Yong Hua | Adhesive including medicament |
US6553998B2 (en) * | 1997-09-12 | 2003-04-29 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6562374B1 (en) * | 2000-06-23 | 2003-05-13 | Korea Institute Of Science And Technology | Biodegradable porous polymer scaffolds for tissue engineering prepared from an effervescent mixture and its preparation |
US6586246B1 (en) * | 1999-03-18 | 2003-07-01 | Innotech Medical, Inc. | Preparing porous biodegradable polymeric scaffolds for tissue engineering using effervescent salts |
US20030180344A1 (en) * | 2002-02-05 | 2003-09-25 | Cambridge Scientific, Inc. | Bioresorbable osteoconductive compositions for bone regeneration |
US6689339B1 (en) * | 1997-11-07 | 2004-02-10 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
US6720374B2 (en) * | 2001-06-19 | 2004-04-13 | Riken Vitamin Co., Ltd. | Aliphatic polyester composition and flexible products |
US20050123590A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Wound dressings and methods |
US20060055089A1 (en) * | 1999-09-17 | 2006-03-16 | Zhang John J | Zoned radiation crosslinked elastomeric materials |
US20060199876A1 (en) * | 2005-03-04 | 2006-09-07 | The University Of British Columbia | Bioceramic composite coatings and process for making same |
US7700819B2 (en) * | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
NL189176B (nl) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | Pleister op basis van een synthetische rubber. |
GB833587A (en) * | 1957-08-30 | 1960-04-27 | Pritchett & Gold & E P S Co | Improvements relating to plastic materials |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
DE2640413C3 (de) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Katheter-Überwachungsgerät |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
EP0035583B1 (de) | 1980-03-11 | 1985-08-14 | Schmid, Eduard, Dr.Dr.med. | Hauttransplantations-Druckverband |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
DE3361779D1 (en) | 1982-07-06 | 1986-02-20 | Dow Corning | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
EP0256060A1 (en) | 1986-01-31 | 1988-02-24 | OSMOND, Roger L. W. | Suction system for wound and gastro-intestinal drainage |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
DE3634569A1 (de) | 1986-10-10 | 1988-04-21 | Sachse Hans E | Kondomkatheter, ein harnroehrenkatheter zur verhinderung von aufsteigenden infektionen |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5376376A (en) | 1992-01-13 | 1994-12-27 | Li; Shu-Tung | Resorbable vascular wound dressings |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
DE4306478A1 (de) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainagevorrichtung, insbesondere Pleuradrainagevorrichtung, und Drainageverfahren |
FR2705567A1 (fr) * | 1993-05-25 | 1994-12-02 | Smith & Nephew Laboratoires Fi | Microparticules, procédé de préparation et application aux pansements. |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
ATE270561T1 (de) | 1994-08-22 | 2004-07-15 | Kinetic Concepts Inc | Kanister |
DE29504378U1 (de) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Elektronisch geregelte Niedervakuumpumpe für die Thorax- und Wunddrainage |
US6096344A (en) | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
CA2263767A1 (en) * | 1996-10-04 | 1998-04-09 | E.I. Du Pont De Nemours And Company | Polyester fiber |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
AU4176101A (en) | 2000-02-24 | 2001-09-03 | Venetec Int Inc | Universal catheter anchoring system |
SE518528C2 (sv) | 2000-12-27 | 2002-10-22 | Artimplant Ab | Ett förfarande för framställning av ett öppet poröst polymermaterial samt ett öppet poröst polymermaterial |
US20020142992A1 (en) * | 2001-03-28 | 2002-10-03 | Scherr George H. | Cellulosic foam compositions |
GB2376632B (en) * | 2001-06-21 | 2004-10-27 | Johnson & Johnson Medical Ltd | Removable cavity wound dressing |
MXPA04008221A (es) * | 2003-02-18 | 2004-11-26 | H Scherr George | Composiciones de espuma de alginato. |
DE102004022645A1 (de) | 2004-05-07 | 2005-12-15 | Resorba Wundversorgung Gmbh & Co. Kg | Bioresorbierbares Material auf Kollagen-Basis |
GB2415382A (en) | 2004-06-21 | 2005-12-28 | Johnson & Johnson Medical Ltd | Wound dressings for vacuum therapy |
CA2571232C (en) | 2004-07-30 | 2010-02-16 | The University Of British Columbia | Method for producing hydrocolloid foams |
CN101534762B (zh) | 2006-11-09 | 2012-09-05 | 凯希特许有限公司 | 适合伤口的多孔生物可吸收敷料及其制备方法 |
GB0707758D0 (en) * | 2007-04-21 | 2007-05-30 | Smith & Nephew | A foam material for medical use and method for producing same |
-
2007
- 2007-11-09 CN CN2007800415741A patent/CN101534762B/zh not_active Expired - Fee Related
- 2007-11-09 KR KR1020097011825A patent/KR20090082468A/ko not_active IP Right Cessation
- 2007-11-09 JP JP2009536319A patent/JP5850516B2/ja not_active Expired - Fee Related
- 2007-11-09 CN CN200780041708XA patent/CN101605518B/zh not_active Expired - Fee Related
- 2007-11-09 EP EP14173292.5A patent/EP2783665B1/en active Active
- 2007-11-09 AU AU2007319939A patent/AU2007319939B2/en not_active Ceased
- 2007-11-09 WO PCT/US2007/023667 patent/WO2008057600A2/en active Application Filing
- 2007-11-09 EP EP07867406.6A patent/EP2079417B1/en active Active
- 2007-11-09 EP EP07870865.8A patent/EP2079418B1/en active Active
- 2007-11-09 AU AU2007317809A patent/AU2007317809B2/en not_active Ceased
- 2007-11-09 US US11/983,549 patent/US8110216B2/en not_active Expired - Fee Related
- 2007-11-09 US US11/983,548 patent/US20080114277A1/en not_active Abandoned
- 2007-11-09 KR KR1020097011827A patent/KR20090085677A/ko not_active IP Right Cessation
- 2007-11-09 SG SG2011079209A patent/SG175690A1/en unknown
- 2007-11-09 WO PCT/US2007/023668 patent/WO2008060475A2/en active Application Filing
- 2007-11-09 TW TW096142609A patent/TWI362925B/zh not_active IP Right Cessation
- 2007-11-09 TW TW096142607A patent/TW200838478A/zh unknown
- 2007-11-09 CA CA2663774A patent/CA2663774C/en not_active Expired - Fee Related
- 2007-11-09 CN CN201310053793.9A patent/CN103169571B/zh not_active Expired - Fee Related
- 2007-11-09 JP JP2009536320A patent/JP5249236B2/ja not_active Expired - Fee Related
- 2007-11-09 CA CA2666530A patent/CA2666530C/en not_active Expired - Fee Related
-
2009
- 2009-04-16 ZA ZA2009/02780A patent/ZA200902780B/en unknown
- 2009-05-05 IL IL198584A patent/IL198584A0/en unknown
- 2009-05-05 IL IL198585A patent/IL198585A0/en unknown
- 2009-05-28 NO NO20092082A patent/NO20092082L/no not_active Application Discontinuation
- 2009-06-03 NO NO20092144A patent/NO20092144L/no not_active Application Discontinuation
-
2010
- 2010-01-30 HK HK10101083.4A patent/HK1134008A1/xx not_active IP Right Cessation
-
2012
- 2012-01-20 US US13/355,266 patent/US8273368B2/en active Active
- 2012-08-13 US US13/584,373 patent/US8496959B2/en not_active Expired - Fee Related
-
2013
- 2013-03-18 JP JP2013055542A patent/JP5722372B2/ja not_active Expired - Fee Related
- 2013-07-15 US US13/942,382 patent/US8852627B2/en active Active
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) * | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) * | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) * | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
US2682873A (en) * | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
US2969057A (en) * | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3367332A (en) * | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) * | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) * | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
US3648692A (en) * | 1970-12-07 | 1972-03-14 | Parke Davis & Co | Medical-surgical dressing for burns and the like |
US3826254A (en) * | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US4096853A (en) * | 1975-06-21 | 1978-06-27 | Hoechst Aktiengesellschaft | Device for the introduction of contrast medium into an anus praeter |
US4245630A (en) * | 1976-10-08 | 1981-01-20 | T. J. Smith & Nephew, Ltd. | Tearable composite strip of materials |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) * | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) * | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) * | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4256109A (en) * | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
US4275721A (en) * | 1978-11-28 | 1981-06-30 | Landstingens Inkopscentral Lic, Ekonomisk Forening | Vein catheter bandage |
US4382441A (en) * | 1978-12-06 | 1983-05-10 | Svedman Paul | Device for treating tissues, for example skin |
US4284079A (en) * | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) * | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) * | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4333468A (en) * | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) * | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) * | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) * | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4608041A (en) * | 1981-10-14 | 1986-08-26 | Frese Nielsen | Device for treatment of wounds in body tissue of patients by exposure to jets of gas |
US4525166A (en) * | 1981-11-21 | 1985-06-25 | Intermedicat Gmbh | Rolled flexible medical suction drainage device |
US4475909A (en) * | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
US4540412A (en) * | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) * | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) * | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
US4897081A (en) * | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) * | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
US4664662A (en) * | 1984-08-02 | 1987-05-12 | Smith And Nephew Associated Companies Plc | Wound dressing |
US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) * | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) * | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) * | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) * | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4758220A (en) * | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) * | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
US4838883A (en) * | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
US4906233A (en) * | 1986-05-29 | 1990-03-06 | Terumo Kabushiki Kaisha | Method of securing a catheter body to a human skin surface |
US4840187A (en) * | 1986-09-11 | 1989-06-20 | Bard Limited | Sheath applicator |
US4743232A (en) * | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
US4953565A (en) * | 1986-11-26 | 1990-09-04 | Shunro Tachibana | Endermic application kits for external medicines |
US4941882A (en) * | 1987-03-14 | 1990-07-17 | Smith And Nephew Associated Companies, P.L.C. | Adhesive dressing for retaining a cannula on the skin |
US4863449A (en) * | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) * | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) * | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) * | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
US4919654A (en) * | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5086170A (en) * | 1989-01-16 | 1992-02-04 | Roussel Uclaf | Process for the preparation of azabicyclo compounds |
US4948575A (en) * | 1989-01-24 | 1990-08-14 | Minnesota Mining And Manufacturing Company | Alginate hydrogel foam wound dressing |
US5527293A (en) * | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5100396A (en) * | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5298015A (en) * | 1989-07-11 | 1994-03-29 | Nippon Zeon Co., Ltd. | Wound dressing having a porous structure |
US5232453A (en) * | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
US5134994A (en) * | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) * | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5525646A (en) * | 1991-03-04 | 1996-06-11 | Lundgren; Dan | Bioresorbable material and an article of manufacture made of such material for medical use |
US5149331A (en) * | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5278100A (en) * | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5645081A (en) * | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5279550A (en) * | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5792469A (en) * | 1992-03-12 | 1998-08-11 | Atrix Laboratories, Inc. | Biodegradable in situ forming film dressing |
US5437622A (en) * | 1992-04-29 | 1995-08-01 | Laboratoire Hydrex (Sa) | Transparent adhesive dressing with reinforced starter cuts |
US5342376A (en) * | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5344415A (en) * | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437651A (en) * | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5766631A (en) * | 1993-09-21 | 1998-06-16 | Arnold; Peter Stuart | Wound implant materials |
US5549584A (en) * | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5556375A (en) * | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) * | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5641502A (en) * | 1995-06-07 | 1997-06-24 | United States Surgical Corporation | Biodegradable moldable surgical material |
US5863297A (en) * | 1995-10-11 | 1999-01-26 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
US5716413A (en) * | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
US6553998B2 (en) * | 1997-09-12 | 2003-04-29 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6689339B1 (en) * | 1997-11-07 | 2004-02-10 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
US6071267A (en) * | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6586246B1 (en) * | 1999-03-18 | 2003-07-01 | Innotech Medical, Inc. | Preparing porous biodegradable polymeric scaffolds for tissue engineering using effervescent salts |
US6287316B1 (en) * | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US20060055089A1 (en) * | 1999-09-17 | 2006-03-16 | Zhang John J | Zoned radiation crosslinked elastomeric materials |
US20020120185A1 (en) * | 2000-05-26 | 2002-08-29 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6562374B1 (en) * | 2000-06-23 | 2003-05-13 | Korea Institute Of Science And Technology | Biodegradable porous polymer scaffolds for tissue engineering prepared from an effervescent mixture and its preparation |
US6345523B1 (en) * | 2000-09-29 | 2002-02-12 | Lambert Kuo | Figure wheel of a combination lock |
US20020077661A1 (en) * | 2000-12-20 | 2002-06-20 | Vahid Saadat | Multi-barbed device for retaining tissue in apposition and methods of use |
US7700819B2 (en) * | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US20020115951A1 (en) * | 2001-02-22 | 2002-08-22 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US6720374B2 (en) * | 2001-06-19 | 2004-04-13 | Riken Vitamin Co., Ltd. | Aliphatic polyester composition and flexible products |
US20030044380A1 (en) * | 2001-07-19 | 2003-03-06 | Zhu Yong Hua | Adhesive including medicament |
US20030180344A1 (en) * | 2002-02-05 | 2003-09-25 | Cambridge Scientific, Inc. | Bioresorbable osteoconductive compositions for bone regeneration |
US20050123590A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Wound dressings and methods |
US20060199876A1 (en) * | 2005-03-04 | 2006-09-07 | The University Of British Columbia | Bioceramic composite coatings and process for making same |
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8235939B2 (en) | 2006-02-06 | 2012-08-07 | Kci Licensing, Inc. | System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment |
US8617140B2 (en) | 2006-03-14 | 2013-12-31 | Kci Licensing, Inc. | System for percutaneously administering reduced pressure treatment using balloon dissection |
US20090157017A1 (en) * | 2006-03-14 | 2009-06-18 | Archel Ambrosio | Bioresorbable foaming tissue dressing |
US20070219489A1 (en) * | 2006-03-14 | 2007-09-20 | Johnson Royce W | Method for percutaneously administering reduced pressure treatment using balloon dissection |
US9456860B2 (en) | 2006-03-14 | 2016-10-04 | Kci Licensing, Inc. | Bioresorbable foaming tissue dressing |
US9050402B2 (en) | 2006-03-14 | 2015-06-09 | Kci Licensing, Inc. | Method for percutaneously administering reduced pressure treatment using balloon dissection |
US8029498B2 (en) | 2006-03-14 | 2011-10-04 | Kci Licensing Inc. | System for percutaneously administering reduced pressure treatment using balloon dissection |
US8939933B2 (en) | 2006-03-14 | 2015-01-27 | Kci Licensing, Inc. | Manifolds, systems, and methods for administering reduced pressure to a subcutaneous tissue site |
US8771253B2 (en) | 2006-03-14 | 2014-07-08 | Kci Licensing, Inc. | System and method for percutaneously administering reduced pressure treatment using a flowable manifold |
US8267918B2 (en) | 2006-03-14 | 2012-09-18 | Kci Licensing, Inc. | System and method for percutaneously administering reduced pressure treatment using a flowable manifold |
US8338402B2 (en) | 2006-05-12 | 2012-12-25 | Smith & Nephew Plc | Scaffold |
US20100297208A1 (en) * | 2006-05-12 | 2010-11-25 | Nicholas Fry | Scaffold |
US9877731B2 (en) | 2006-06-15 | 2018-01-30 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10226258B2 (en) | 2006-06-15 | 2019-03-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9724103B2 (en) | 2006-06-15 | 2017-08-08 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US11160557B2 (en) | 2006-06-15 | 2021-11-02 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US11185336B2 (en) | 2006-06-15 | 2021-11-30 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9259228B2 (en) | 2006-06-15 | 2016-02-16 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9451963B2 (en) | 2006-06-15 | 2016-09-27 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10499925B2 (en) | 2006-06-15 | 2019-12-10 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9486221B2 (en) | 2007-12-21 | 2016-11-08 | Microvision, Inc. | Hydrogel filaments for biomedical uses |
US10194915B2 (en) | 2007-12-21 | 2019-02-05 | Microvention, Inc. | Implantation devices including hydrogel filaments |
WO2010078209A3 (en) * | 2008-12-31 | 2010-11-04 | Kci Licensing, Inc. | Bioresorbable foaming tissue dressing |
CN102264400A (zh) * | 2008-12-31 | 2011-11-30 | 凯希特许有限公司 | 生物可吸收的发泡组织敷料 |
US20120150188A1 (en) * | 2009-04-17 | 2012-06-14 | Mccarthy Stephen | Absorbable bone adhesive applicator |
US9993252B2 (en) | 2009-10-26 | 2018-06-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10918527B2 (en) | 2010-01-22 | 2021-02-16 | Kci Licensing, Inc. | Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy |
US20210128362A1 (en) * | 2010-01-22 | 2021-05-06 | Kci Licensing, Inc. | Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy |
US9974693B2 (en) | 2010-01-22 | 2018-05-22 | Kci Licensing, Inc. | Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy |
US20110184357A1 (en) * | 2010-01-22 | 2011-07-28 | Kci Licensing, Inc. | Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy |
US20130274717A1 (en) * | 2011-04-15 | 2013-10-17 | Raymond Dunn | Surgical cavity drainage and closure system |
WO2012142473A1 (en) * | 2011-04-15 | 2012-10-18 | University Of Massachusetts | Surgical cavity drainage and closure system |
US11000418B2 (en) | 2011-04-15 | 2021-05-11 | University Of Massachusetts | Surgical cavity drainage and closure system |
US9597484B2 (en) | 2011-04-15 | 2017-03-21 | University Of Massachusetts | Surgical cavity drainage and closure system |
US10166148B2 (en) * | 2011-04-15 | 2019-01-01 | University Of Massachusetts | Surgical cavity drainage and closure system |
US20160317792A9 (en) * | 2011-04-15 | 2016-11-03 | University Of Massachusetts | Surgical cavity drainage and closure system |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US11957814B2 (en) | 2011-05-31 | 2024-04-16 | Lifecell Corporation | Adipose tissue matrices |
US9381278B2 (en) | 2012-04-18 | 2016-07-05 | Microvention, Inc. | Embolic devices |
US10201562B2 (en) | 2012-06-14 | 2019-02-12 | Microvention, Inc. | Polymeric treatment compositions |
US11331340B2 (en) | 2012-06-14 | 2022-05-17 | Microvention, Inc. | Polymeric treatment compositions |
US9937201B2 (en) | 2012-06-14 | 2018-04-10 | Microvention, Inc. | Polymeric treatment compositions |
US10588923B2 (en) | 2012-06-14 | 2020-03-17 | Microvention, Inc. | Polymeric treatment compositions |
US9351993B2 (en) | 2012-06-14 | 2016-05-31 | Microvention, Inc. | Polymeric treatment compositions |
US11090338B2 (en) | 2012-07-13 | 2021-08-17 | Lifecell Corporation | Methods for improved treatment of adipose tissue |
US10709810B2 (en) | 2012-09-26 | 2020-07-14 | Lifecell Corporation | Processed adipose tissue |
US9370536B2 (en) | 2012-09-26 | 2016-06-21 | Lifecell Corporation | Processed adipose tissue |
US10828388B2 (en) | 2012-10-15 | 2020-11-10 | Microvention, Inc. | Polymeric treatment compositions |
US9655989B2 (en) | 2012-10-15 | 2017-05-23 | Microvention, Inc. | Polymeric treatment compositions |
US11801326B2 (en) | 2012-10-15 | 2023-10-31 | Microvention, Inc. | Polymeric treatment compositions |
US10258716B2 (en) | 2012-10-15 | 2019-04-16 | Microvention, Inc. | Polymeric treatment compositions |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
US10946100B2 (en) | 2014-04-29 | 2021-03-16 | Microvention, Inc. | Polymers including active agents |
US10226533B2 (en) | 2014-04-29 | 2019-03-12 | Microvention, Inc. | Polymer filaments including pharmaceutical agents and delivering same |
US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
US11759547B2 (en) | 2015-06-11 | 2023-09-19 | Microvention, Inc. | Polymers |
US10639398B2 (en) | 2016-07-05 | 2020-05-05 | Lifecell Corporation | Tissue matrices incorporating multiple tissue types |
US11911041B2 (en) | 2016-08-26 | 2024-02-27 | Microvention, Inc. | Embolic compositions |
US11051826B2 (en) | 2016-08-26 | 2021-07-06 | Microvention, Inc. | Embolic compositions |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
US20180325741A1 (en) * | 2017-05-15 | 2018-11-15 | Baxter International Inc. | Biodegradable negative pressure wound therapy dressing |
US10576182B2 (en) | 2017-10-09 | 2020-03-03 | Microvention, Inc. | Radioactive liquid embolic |
US11123375B2 (en) | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
US10821205B2 (en) | 2017-10-18 | 2020-11-03 | Lifecell Corporation | Adipose tissue products and methods of production |
US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
US11826488B2 (en) | 2017-10-19 | 2023-11-28 | Lifecell Corporation | Flowable acellular tissue matrix products and methods of production |
US11633521B2 (en) | 2019-05-30 | 2023-04-25 | Lifecell Corporation | Biologic breast implant |
CN113303974A (zh) * | 2021-05-26 | 2021-08-27 | 华中科技大学同济医学院附属协和医院 | 新型无菌压疮敷料及其制造方法 |
CN114533935A (zh) * | 2022-02-28 | 2022-05-27 | 浙江卫未生物医药科技有限公司 | 一种用于解决青春痘的细胞因子敷料及其制备方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2079418B1 (en) | Porous bioresorbable dressing conformable to a wound and methods of making same | |
CN111432761B (zh) | 延长穿戴时间的敷料 | |
US10893982B2 (en) | Perforated, layered wound treatment material | |
RU2710345C2 (ru) | Системы и способы для заживления ткани | |
RU2436556C2 (ru) | Пористая биорассасываемая повязка, соответствующая размерам раны, и способы ее получения | |
RU2433834C2 (ru) | Пористая биологически рассасываемая включающая микросферы повязка и способ ее изготовления | |
AU2013205713A1 (en) | Porous bioresorbable linked dressing comprising microspheres and methods of making same | |
CN108697829B (zh) | 改进的基于纤维蛋白原的组织粘合贴片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KCI LICENSING, INC, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AMBROSIO, ARCHEL;PAYNE, JOANNA;KIESWETTER, KRISTINE;REEL/FRAME:020388/0404 Effective date: 20080109 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |